Novus Biologicals Ranked in the Inc. 5000 - Inc. Magazine's List of America’s Fastest-Growing Private Companies

Littleton, CO - August 30th, 2010 - Inc. magazine ranked Novus Biologicals no.2627 on its fourth annual Inc. 5000, an exclusive ranking of the nation's fastest-growing private companies. The list represents the most comprehensive look at the most important segment of the economy—America’s independent-minded entrepreneurs.

MBC Pharma Inc. Awarded a SBIR Phase II Grant to Investigate Novel Compounds for Prostate Cancer

Aurora, CO – August 27, 2010 - MBC Pharma Inc., a privately held biopharmaceutical company announced today, that it has been awarded an $1,795,054  phase II Small Business Innovation Research (SBIR) grant from the U.S. National Institutes of Health (NIH). MBC will use this 2-year grant to further expand their discovery pipeline of bone-targeted chemotherapeutics for the treatment of cancer induced bone disease.  The work will focus on the synthesis and efficacy testing of novel bone-targeted conjugates of agents with known activities against prostate cancers.

Emerging biotechnology company Sharklet Technologies, Inc. moves corporate headquarters to Fitzsimons Life Science District in Aurora, Colo.

August 16, 2010

AURORA, COLO. – Sharklet Technologies, Inc. today announced that it has relocated its corporate headquarters from Alachua, Fla. to Aurora, Colo. The company will be housed at the Bioscience Park Center, a biotechnology incubator in the Fitzsimons Life Science District adjacent to the renowned Anschutz Medical Campus. Sharklet Technologies will situate its executive offices and main research laboratory at the Colorado facility.

Free Trial Offer: ampliPHOX Colorimetric Detection Technology for Low-Density Microarrays

BOULDER, CO--(Marketwire - August 4, 2010) - InDevR, developer of advanced life science products, announced that it is seeking scientists interested in participating in extensive beta site testing of its ampliPHOX Colorimetric Detection Technology for low density microarrays. Based on the overwhelming success of initial beta site testing, InDevR plans to significantly expand testing by offering a free trial kit (instrument and reagents) to scientists currently working with low density microarrays or assays that utilize biotinylated targets immobilized on transparent substrates.

InDevR’s ampliPHOX Technology Featured at ASM National Meeting

July 23, 2010

InDevR’s ampliPHOX Colorimetric Detection Technology, currently in beta testing with a collaborator, USDA/ARS/WRRC, Produce Safety and Microbiology Research Unit in Albany, CA., was highlighted at the recent American Society for Microbiology National Meeting. A poster detailing work on E. coli detection using ampliPHOX Detection Technology was presented and well received. The presentation was entitled:  “Use of photopolymerization for the rapid and cost-effective identification of Shiga toxin-producing Escherichia coli on DNA microarrays”.

Exalenz Bioscience and Sandhill Scientific Partner to Deliver Advanced Breath Testing Solutions for H. pylori Assessment to the Gastroenterology Market

July 19, 2010

NEWFIELDS, N.H. – Exalenz Bioscience, Inc., a medical device company specializing in the diagnosis and monitoring of gastroenterological and liver related diseases, today announced it has entered into a multi-year, strategic relationship with Sandhill Scientific, Inc., a leading manufacturer and marketer of innovative gastroenterology devices, to promote the BreathID® Breath Test System and Exalenz’ full line of H. pylori diagnostic solutions to gastroenterologists throughout the United States.

The New Colorado Green – “Grown Locally, Compete Globally” An overview of WIRED Grants for Bioscience in Northern Colorado

July 12, 2010

Fort Collins, Colorado (July 12th, 2010) – The only way out of a recession is growth, and that requires innovative thinking and a skilled workforce. Over the past four years Colorado has leveraged a Workforce Innovation in Regional Economic Development (WIRED) grant from the U.S. Department of Labor to train approximately 2,500 individuals for careers in aerospace, bioscience, energy, and information technology.

NC Wired Grants Information

Roche Honors Colorado State University Professor, Student as Next Generation Chemists

July 8, 2010

FORT COLLINS - Roche, a leading pharmaceutical company, has recognized Colorado State University Professor Tomislav Rovis and his doctoral student, Daniel DiRocco, for their research accomplishments as next-generation chemists.

Griff/SMC Marks 35th Anniversary with New Website

July 2, 2010

BOULDER, CO—Griff/SMC, one of the nation's leading medical marketing communications firms and the oldest full-service advertising agency in Boulder, Colorado, is celebrating its 35th year in business.

Novus Biologicals and AmideBio sign distribution agreement

July 1, 2010

Novus Biologicals, LLC executed an exclusive distribution agreement  with Boulder-based startup, AmideBio, LLC to distribute their line of peptides to bioscience researchers worldwide. 

Cerapedics, Inc. receives CE mark for i-FACTOR™ Flex bone graft

June 30, 2010

Limited market release of Cerapedics’ second peptide-enhanced bone graft product for spine, trauma and orthopedic applications in Europe and Asia Pacific

CoorsTek to buy advanced-ceramics business of Saint-Gobain

June 28, 2010

Denver Business Journal

CoorsTek Inc., which makes technical ceramic and specialty material components, said Monday it has agreed to buy the advanced-ceramics business of France's Saint-Gobain SA..

Pinnacle Biopharma LLC

June 28, 2010

Pinnacle Biopharma LLC has been awarded the contract for operation of Colorado State University's new manufacturing faciliy, part of the Research Innovation Center in Fort Collins.  This move will bring an estimated 30 new jobs to Northern Colorado.  Pinnacle’s management expertise covers all aspects of Good Manufacturing Practices (GMP); quality management, pharmaceutical development, regulatory affairs, business development and executive management.

Boulder BioMed obtains ISO 13485:2003

BOULDER, COLORADO, JUNE 22, 2010

Boulder BioMed today announced successful certification to ISO 13485: 2003, Quality Management Standard for Medical Devices. Company President and CEO Jim Kasic personally thanks Gabe Orosco, of Reglera, who coordinated the certification process. The certification to this standard, an internationally recognized management system standard developed by the International Organization for Standardization (ISO), is a requirement for the manufacturing of commercial medical devices. Boulder BioMed is an innovative product and technology acceleration commercialization company specializing in bringing medical products to market.

Optioned technology is a minimally-invasive means of diagnosing acid reflux and other esophageal diseases

AURORA, Colo. – June 21, 2010 – A diagnostic device developed at the University of Colorado Denver School of Medicine and the University of Illinois at Chicago College of Medicine was recently optioned by Sandhill Scientific, Inc., a Colorado-based company developing diagnostic devices for a variety of gastrointestinal illnesses.

New Study on Innovation Shows Challenges Facing Colorado’s Medical Research Workers

June 16, 2010

This study was undertaken for the Council for American Medical Innovation (CAMI) by the Battelle Technology Partnership Practice.

The Japanese Red Cross Considers CaridianBCT's Mirasol Pathogen Reduction Technologies System

June 16, 2010

Mirasol System identified as the Best Available Technology for Japanese Needs

InDevR to Collaborate with Scientists at the CDC to Develop New Influenza Virus Surveillance Assay

June 15, 2010

InDevR, developer of advanced life science products, announced its collaboration with scientists in the Influenza Division of the Centers for Disease Control and Prevention (CDC) in Atlanta to develop a unique influenza microarray assay.

Omni Bio Announces FDA IND Clearance for Alpha-1 Antitrypsin (AAT) Type 1 Diabetes Clinical Trial

June 8, 2010

Screening Underway at Barbara Davis Center for Childhood Diabetes at University of Colorado Denver Anschutz Medical Campus.

Medical Technology Industry Upadate

June 7, 2010

Complete AdvaMed Report by The Lewin Group

Key Findings

AdvaMed Testimony submitted

50 Colorado companies to watch 2010

Colorado Biz

June 1, 2010

The second annual 50 Colorado Companies to Watch features snapshots of businesses that are thriving – and growing – as selected by the Colorado Office of Economic Development and International Trade and economic development groups and chambers of commerce statewide.

Including the following bioscience companies:  Biodesix, E.I. Medical Imaging, Forensic Laboratories, InDevR, Inviragen, Mile High Orthodics (A&M Labs), OPX Biotechnologies

Array BioPharma Signs Strategic Oncology Collaboration

April 19, 2010

Array BioPharma announced that it has entered into an agreement with Novartis for the worldwide development of its MEK inhibitors.

Colorado's Pico-Tesla opening East Coast HQ in Florida

April 4, 2010

Pico-Tesla Magnetic Therapies LLC of Colorado is opening an East Coast headquarters in Clearwater, Fla.

InDevR and Sales Partnerships Inc. Announce Strategic Alliance for InDevR’s Virus Counter Product Line

April 1, 2010

InDevR, developer of advanced life science products, announced today that it is teaming up with Sales Partnerships Inc. to expand sales capabilities for its new Virus Counter product line.

External Experts Agree CaridianBCT’s Pathogen Reduction Technology Offers Effective Alternative to Gamma Irradiation for Preventing Transfusion-Associated Graft vs. Host Disease

March 31, 2010

BRUSSELS – CaridianBCT, a leading global provider of technology, products and services in the blood banking, transfusion medicine and cell therapy industries, today announced that a panel of medical and scientific experts have endorsed the effectiveness of the Mirasol® Pathogen Reduction Technology (PRT) System for replacing gamma irradiation, the current standard of care for preventing transfusion-related Graft vs. Host Disease (GVHD) in platelet recipients. GVHD is an infrequent but often fatal complication associated with transfusion of cellular blood components in patients with suppressed immune systems.

Flashback Technologies to Commercialize University of Colorado Cardiovascular Monitoring Technology

March 29, 2010

AURORA – The University of Colorado recently completed a license agreement with Flashback Technologies, LLC for CU technology enabling fast, non-invasive detection of acute blood loss volume and prediction of cardiovascular collapse in emergency situations.

Arca biopharma receives U.S. patent

March 26, 2010

Boulder County Business Report

BROOMFIELD – Financially strapped Arca biopharma Inc. received a U.S. patent for methods of treating heart failure with bucindolol, the basis for its Gencaro drug.

BIC partners with School of Mines

March 23, 2010

Boulder County Business Report

BOULDER – The Boulder Innovation Center will expand and share its University of Colorado at Boulder-based research commercialization program with the Colorado School of Mines Office of Technology Transfer in Golden.

Beacon Biotechnology LLC to present at the 42nd Oak Ridge Conference

March 23, 2010

Beacon Biotechnology LLC (Aurora, CO) announced that it has been invited to make an oral presentation to the meeting body of its poster describing the BrightSPOT™ System to the 42nd Oak Ridge Conference. The BrightSPOT System is an inexpensive, single-use disposable multiplexed platform for protein and nucleic acid detection methods. Providing more than 100 simultaneous test results on a drop of sample, Beacon’s BrightSPOT technology is unique in that it does not require an instrument; the disposable is the ‘instrument’. Occurring in San Jose, CA this year on April 22-23, 2010, the annual Oak Ridge Conference draws researchers and life science industry experts to review promising leading-edge technologies.

MicroPhage, Inc. appoints Alene A. Campbell as CEO

March 18, 2010

LONGMONT – MicroPhage announced today that it has appointed Alene A. Campbell as its chief executive officer, effective immediately. Ms. Campbell, who has served MicroPhage for the past two years as its Chief Operations Officer, replaces Steve Lundy, who has resigned.

Judge sides with Monsanto in sugar-beet dispute

March 17, 2010

A federal judge denied a request by organic seed growers as well as conservation and food safety groups seeking a temporary ban on Monsanto Co.’s genetically engineered sugar beets.

Bioxclude™: The Birth Of A Natural, Bioresorbable Membrane

March 16, 2010

Denver – Snoasis Medical, Inc. introduces BioXclude, a processed, dehydrated and terminally sterilized graft composed of human amnion and chorion tissue. BioXclude represents the first allograft sourced from donated placental tissue for use as a wound covering in guided bone regeneration procedures. Distribution of BioXclude commenced this past weekend at the Academy of Osseointegration in Orlando, March 4-6, 2010. BioXclude is the second product from Snoasis Medical, a dental company based out of Denver, Colorado.

2010 Governor’s Export Award (introductory letter and application)

March 15, 2010

The Governor’s Award for Excellence in Exporting honors Colorado’s outstanding exporters, highlighting the importance of such companies in the development of our state’s economy. The award has been given every year since 1970 and recognizes Colorado companies that demonstrate an outstanding commitment to engaging in international trade.

Wi Inc. is Presenting at the Biodot Workshop in San Diego March 30th-April 1st

March 15, 2010

Wi is pleased to announce that Steve Jackinsky, Director of Diagnostics will be presenting on Tuesday, March 30 at 2:30pm and speaking on the topic "How to Transform a Benchtop Assay into a Lab-on-Card Platform." Reflecting the workshop theme, Steve will discuss Wi's innovative technology for quantitative, rapid diagnostic tests.

Pico-Tesla closes first tranche in Series A capital raise

March 15, 2010

LITTLETON – Pico-Tesla, The Magneceutical™ Therapy Company, announced today that it has received the first tranche, $1 million, of a $4 million Series A capital raise. Pico-Tesla will use some of the proceeds to fund two ongoing clinical trials, as well as initiate new studies.

InDevR ampliPHOX colormetric detection technology in beta site-testing

March 12, 2010

InDevR, developer of advanced life science products, announced that its ampliPHOX Colorimetric Detection Technology is being beta site-tested in anticipation of an upcoming product launch. The original intellectual property was licensed from the University of Colorado at Boulder.

For second year in a row, One-quarter of Fairfield and Woods attorneys named to 2010 Super Lawyer list

March 12, 2010

Denver – Fairfield and Woods, P.C., a mid-size, full-service law firm, announced today that 11 of their lawyers were named to the Colorado Super Lawyers List. This group puts one-quarter of the firm’s attorneys on this prestigious list, and represents all areas of the firm’s full-service practice, including both established directors and new rising stars.